A Phase 1b/2a Study of Soticlestat (TAK-935/OV935) as Adjunctive Therapy in Adults With Developmental and/or Epileptic Encephalopathies (DEE)

Publication/Presentation Date

4-2020

Volume

94

Issue

15

First Page

4715

Last Page

4715

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine

Document Type

Article

Share

COinS